MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
159 hedge funds and large institutions have $2.01B invested in Momenta Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 60 increasing their positions, 50 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 160 → 159 (-1)
Holders
159
Holding in Top 10
1
Calls
$3.86M
Puts
$2.48M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$16M | |
| 3 | +$10.5M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.37M |
Top Sellers
| 1 | -$56.4M | |
| 2 | -$14.9M | |
| 3 | -$9.91M | |
| 4 |
D.E. Shaw & Co
New York
|
-$7.22M |
| 5 |
TA
Teachers Advisors
New York
|
-$6.64M |